Each year The Galien Foundation highlights the latest scientific advancements. It is inspiring to see how far the industry has come in providing treatment options for patients and humbling to know how far we still need to go. To have our HER2 directed #ADC nominated once again for the #PrixGalien Best Biotechnology Product award reflects our team’s passion for innovation and, most importantly, our unwavering focus to help change the standards of care for the patients of today and tomorrow. Thank you to all the nominees and entire oncology community for your continued commitment to patients. Click the image to read more about this prestigious award. #biotechnology #awards
Daiichi Sankyo US
Pharmaceutical Manufacturing
Basking Ridge, NJ 188,754 followers
We create life-changing solutions for patients.
About us
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/3PYTqYr
- Website
-
https://daiichisankyo.us/
External link for Daiichi Sankyo US
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Basking Ridge, NJ
- Type
- Public Company
- Specialties
- Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines., Oncology, and Specialty Medicine
Locations
-
Primary
211 Mt. Airy Road Basking Ridge
Basking Ridge, NJ 07920, US
Employees at Daiichi Sankyo US
-
Jak (J. C.) DeTemple
Top Talent Executive Recruiter to the Biotech/Pharma Industry Leadership Superstars! Top Talent Sourcing Guru! Talent Acquisition & Retention…
-
Hayes Williams
Global Head of Data Governance at Daiichi Sankyo, Inc.
-
Desmon Swanston
-
Joseph Prikazsky
Pharma/Biotech Financial Professional
Updates
-
At Daiichi Sankyo US, we are committed to fostering an environment that embraces each person's unique crafts, faces challenges head on and celebrates the victories of those we serve. 🏥💪 "Team empowerment" is the leadership craft that David L. Merlob, M.S., one of our Coaches of the Year, embodies and a key element of what helps ensure our core values—innovation, integrity and accountability—are more than just words for his team. "We strive to foster a culture where challenges are embraced, and learnings are shared, with a deep understanding that our work directly impacts the patients we serve, making their victories our victories. This team embodies the spirit of collaboration, innovation, and mutual support, and I'm proud to witness their growth and success every day." #DSProud #Inspiration #Culture
-
Daiichi Sankyo US and Merck today announced an agreement to expand their existing global development and commercialization collaboration of three investigational DXd ADCs to include Merck’s investigational delta-like ligand 3 (DLL3) targeting T-cell engager. The expansion of a DLL3 T-cell engager within Daiichi Sankyo US oncology pipeline further supports the company’s ongoing R&D strategy to create new standards of care for people with cancer. Through this expanded agreement, the companies will evaluate the combination of the investigational DDL3 targeting T-cell engager with the investigational B7-H3 directed DXd ADC targeting the underlying biology of small cell lung cancer along with other forms of cancer. Read the press release for additional information on the expanded agreement and to learn more about our collective commitment to develop innovative medicines to help people impacted by cancer.
Press Releases - Daiichi Sankyo US
daiichisankyo.us
-
Biomarker testing has transformed the cancer treatment landscape, significantly improving patient outcomes by identifying ‘actionable’ targets. Just as each lung cancer patient is unique, so too should be their treatment approach. Learn more about how we are advancing biomarker awareness and driving treatment innovations: https://bit.ly/3YpMBWM #BiomarkerTesting #WorldLungCancerDay
-
#BreakingNews: We have initiated the IDeate-Lung02 phase 3 trial for certain patients with relapsed small cell lung cancer (SCLC) in collaboration with Merck. Click the image to learn how Daiichi Sankyo is investigating this potential first-in-class treatment option for certain people impacted by #SCLC.
Press Releases - Daiichi Sankyo US
daiichisankyo.us
-
What's your favorite interview question? Mike Collier likes to ask about your superpower. One of our Coaches of the Year, Mike's superpower is being a "developer". "I will never forget the sales leaders that invested in me, and believed in what I could accomplish. Now I do the same. When I coach my team to get out of their comfort zone and apply for Leadership Development Programs, Regional Councils and more, it helps both the individual and the company grow and thrive." #DSProud #leadership #growth
-
How do you “own” your day? Arianna Huffington, named one of Forbes Most Powerful Women and CEO and Founder of Thrive Global, recently joined Ken Keller, Simon King, Michele Schmidt and the team for a thought-provoking conversation on how to harness the power of choice to do just that. Are you: 📃Practicing mindful prioritization? 💪Focusing on your well-being first? 👹Resetting before/after difficult conversations? At Daiichi Sankyo US, employees have the power to choose how best to do this for themselves and their teams. It’s embedded within our culture—from flexible work schedules, styles and development opportunities to tools, resets and microstep journeys available in the Thrive Global platform—so that we can be our best selves personally, for others and the patients we serve. ⬇COMMENT below with your go-to strategy to own your day.
-
Celebrating its 34th anniversary, the Americans with Disabilities Act assures equal rights, access and opportunities to people with disabilities. 👉SWIPE to explore what that means at Daiichi Sankyo US and a few ways we work to ensure all employees are able to safely perform their job to grow in their careers. #DisabilityAwareness #ThanksToTheADA #ADA34
-
Save the date! Daiichi Sankyo will be attending the National Sales Network 27th Annual Conference in Houston, TX from August 7 – 9. If you’re interested in new opportunities and learning about the innovative work we do, come connect with us at Booth # 425. #NationalSalesNetwork #Hiring #NSN2024
This content isn’t available here
Access this content and more in the LinkedIn app
-
Who did you want to be when you grew up? Doctor, teacher, inventor, leader… The list is endless. But what’s the ‘why’ behind it? A month into their internships and already making a difference in their respective business functions, take a few minutes this #NationalInternDay to learn a bit about our interns and who they want to be. ➡ Faaraan Kazi: “I aim to contribute to groundbreaking projects that leverage machine learning and deep learning to solve real-world problems.” ➡ Nikayla Karda-Marok: “I want to go to law school and become an attorney.” ➡ Ada Wu: “I am deeply motivated and excited by the prospect of working closely with our brilliant scientists and ultimately making a difference in the lives of patients.” ➡ Brianna Elbert: “As of right now, I either want to enter a career in biology research or attend dental school.” ➡ Harrison Kelly: “I have always wanted to run a business, but more importantly a business that makes a difference.” SWIPE for more on 5 of our interns and what drives them in their career journey. #DSProud